User Auth Test Page

US Government Expects To Stop Purchasing COVID-19 Products As Soon As January

Bloomberg (8/30, Griffin, Ruoff) reports, “The US government anticipates that it will stop purchasing and providing COVID-19 shots as soon as January due to a lack of funds, leaving Americans to obtain vaccines through insurers or pay for them out-of-pock...

Full Article
US Health Officials Preparing To Roll Out Updated COVID-19 Vaccine Boosters

ABC News (8/29, Mitropoulos, Haslett) reports US “health officials are preparing to roll out millions of new COVID-19 boosters as health experts grow concerned over a potential viral resurgence in the fall and winter.” The FDA “is expected, as soon as thi...

Full Article
Use Of Oral Tenofovir-Based PrEP For HIV Prevention In HBV-Endemic Countries, High-Risk Populations May Decrease Number Of HIV And HBV Coinfections, Researchers Say

Healio (8/29, Stulpin) reports, “The use of oral tenofovir-based PrEP for HIV prevention in hepatitis B-endemic countries and in high-risk populations could ‘markedly decrease’ the number of HIV and HBV coinfections, researchers found in a review.” But, “...

Full Article
US College Campus Re-Openings Lead To Local Increases In COVID-19 Cases Of More Than A Third, Study Finds

Bloomberg (8/29, Taylor) reports that “college campus re-openings in the US led to local increases in COVID-19 cases of more than a third, according to a study” published in PLOS One. These “increases were greatest among campuses that drew students from a...

Full Article
Biden Administration Signs $11M Deal To Boost Monkeypox Vaccine Manufacturing

Bloomberg (8/29, Muller) reports “the Biden administration signed an $11 million deal to support a Michigan company that’s helping make [the] vaccine against monkeypox.” HHS’ “Biomedical Advanced Research and Development Authority is providing the funding...

Full Article
Many Places In US Shift To New Monkeypox Vaccine Strategy, Report Varying Results

CNN (8/29, Howard) reports, “Most places in the United States with heavy monkeypox caseloads have shifted their vaccination strategies to the Biden administration’s low-dose, intradermal approach – and they are reporting varying results so far.” Some area...

Full Article
US COVID-19 Vaccination Campaign Facing Obstacles Ahead Of Updated Booster Rollout

The New York Times (8/28, Mueller) reports, “At the very moment a better coronavirus vaccine is expected to finally become available, America’s vaccination program is feeling the effects of a long period of retreat.” Some “state health officials, citing w...

Full Article
Federal Website To Suspend Taking Orders For Free At-Home COVID-19 Tests, Biden Administration Announces

USA Today (8/26, Groppe) reported that beginning this week, “the Biden administration will suspend taking orders for free at-home COVID-19 tests because of limited supply, USA TODAY has learned.” USA Today added, “As of Sept. 2, free tests will no longer...

Full Article
Molnupiravir And Nirmatrelvir-Ritonavir Appeared To Have Clinical Benefit In Hospitalized Patients With Mild-To-Moderate COVID-19 Who Did Not Require Oxygen Therapy During Omicron BA.2 Wave, Study Shows

MedPage Today (8/26, Hein) reported, “During the Omicron BA.2 wave, antivirals molnupiravir and nirmatrelvir-ritonavir (Paxlovid) appeared to have clinical benefit in hospitalized patients with mild-to-moderate COVID-19 who did not require oxygen therapy,...

Full Article
COVID-19 Rebound Cases Most Likely More Common Than Data Indicate, Experts Say

CNN (8/26, McPhillips) reported on the prevalence of COVID-19 rebound cases either independent of or associated with treatment, including with Pfizer’s antiviral nirmatrelvir/ritonavir (Paxlovid). A CDC spokesperson said, “From the data we have so far, CO...

Full Article
FDA Authorization Of Updated COVID-19 Boosters To Come Before Testing In Humans Is Completed

The Wall Street Journal (8/28, Whyte, Subscription Publication) reports the FDA is expected to authorize updated COVID-19 vaccine booster shots this week; however, the shots will not have finished undergoing testing in humans when the decisions are made.

Full Article
US Health Officials Cautiously Optimistic In View Of Declining New Monkeypox Cases

The Washington Post (8/26, A1, Diamond) reported that following “three months of surging monkeypox cases, the worldwide outbreak may have peaked, amid evidence that gay men are curbing risky sexual behaviors and more people are getting vaccinated against...

Full Article
Current Outbreak Upends Many Previous Understandings Of Monkeypox

The New York Times (8/26, Mandavilli) reported that at the onset of the monkeypox outbreak, “scientists thought they knew when and how the monkeypox virus was spread, what the disease looked like and who was most vulnerable.” However, “the 44,000 cases id...

Full Article
Moderna Sues Pfizer, BioNTech Over Alleged COVID-19 Vaccine Patent Infringements

The Washington Post (8/26, Rowland) reported, “Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the rival firms improperly used its foundational technology in developing their coronavirus vaccine.” Moderna “said it filed suits...

Full Article
Almost 40% Of People Hospitalized In US With Omicron Subvariant This Spring Were Vaccinated And Boosted, CDC Finds

Bloomberg Law (8/25, Muller, Subscription Publication) reports, “Almost 40% of people hospitalized in the US with the COVID subvariant that circulated this spring were vaccinated and boosted, highlighting how new strains have mutated to more readily escap...

Full Article
FDA Extends Expiration Dates For Some COVID-19 Tests

The Los Angeles Times (8/25, Money) reports “federal regulators have extended” the expiration dates of some COVID-19 tests, “meaning certain offerings are now usable for months longer.” The reason for this extension, the FDA “said, is that in the rush to...

Full Article
Pfizer’s Experimental RSV Vaccine Effective, Safe In Late-Stage Clinical Trial Of Older Adults, Early Data Indicate

NBC News (8/25, Lovelace) reports Pfizer’s experimental vaccine RSVpreF for respiratory syncytial virus (RSV) “was nearly 86% effective in preventing severe illness in a late-stage clinical trial of older adults, the company announced in a release Thursda...

Full Article
COVID-19 Hospitalizations Steadily Rose In Children Under Five Over Summer, CDC Data Show

USA Today (8/25, Rodriguez) reports this “summer saw [COVID-19] hospitalizations steadily climb in” children younger than five years, “and health experts worry the trend will continue as children return to school and day care facilities,” and as “pediatri...

Full Article
Number Of Monkeypox Cases Reported Globally Dropped 21% In Last Week, WHO Says

The AP (8/25) reports, “The number of monkeypox cases reported globally dropped 21% in the last week, reversing a month-long trend of rising infections and signaling that Europe’s outbreak may be starting to decline, the World Health Organization said Thu...

Full Article
New “Tomato Flu” Spreading Among Children In India

The Washington Post (8/25, Jeong) reports, “A new, highly contagious viral infection that has been dubbed ‘tomato flu’ is spreading among children in India, the country’s Health Ministry said this week.” The Post adds, “At least 82 children under age 5 ha...

Full Article

Request a Call from Customer Relations

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

First Name *
Last Name *
Email *
Customer ID

US Government Expects To Stop Purchasing COVID-19 Products As Soon As January

US Health Officials Preparing To Roll Out Updated COVID-19 Vaccine Boosters

Use Of Oral Tenofovir-Based PrEP For HIV Prevention In HBV-Endemic Countries, High-Risk Populations May Decrease Number Of HIV And HBV Coinfections, Researchers Say

US College Campus Re-Openings Lead To Local Increases In COVID-19 Cases Of More Than A Third, Study Finds

Biden Administration Signs $11M Deal To Boost Monkeypox Vaccine Manufacturing

Many Places In US Shift To New Monkeypox Vaccine Strategy, Report Varying Results

US COVID-19 Vaccination Campaign Facing Obstacles Ahead Of Updated Booster Rollout

Federal Website To Suspend Taking Orders For Free At-Home COVID-19 Tests, Biden Administration Announces

Molnupiravir And Nirmatrelvir-Ritonavir Appeared To Have Clinical Benefit In Hospitalized Patients With Mild-To-Moderate COVID-19 Who Did Not Require Oxygen Therapy During Omicron BA.2 Wave, Study Shows

COVID-19 Rebound Cases Most Likely More Common Than Data Indicate, Experts Say

FDA Authorization Of Updated COVID-19 Boosters To Come Before Testing In Humans Is Completed

US Health Officials Cautiously Optimistic In View Of Declining New Monkeypox Cases

Current Outbreak Upends Many Previous Understandings Of Monkeypox

Moderna Sues Pfizer, BioNTech Over Alleged COVID-19 Vaccine Patent Infringements

Almost 40% Of People Hospitalized In US With Omicron Subvariant This Spring Were Vaccinated And Boosted, CDC Finds

FDA Extends Expiration Dates For Some COVID-19 Tests

Pfizer’s Experimental RSV Vaccine Effective, Safe In Late-Stage Clinical Trial Of Older Adults, Early Data Indicate

COVID-19 Hospitalizations Steadily Rose In Children Under Five Over Summer, CDC Data Show

Number Of Monkeypox Cases Reported Globally Dropped 21% In Last Week, WHO Says

New “Tomato Flu” Spreading Among Children In India